Clinical Trial

Immunological Characteristics of Preclinical IBD

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated April 15, 2026 (before its estimated July 1, 2026 completion). Its status may not reflect the trial's current state.
Summary
The purpose of this study is to evaluate disease progression, in terms of development of symptomatic disease and complications associated with IBD (e.g. fistula, abscess, stricture).
Protocol Amendment History 7 amendments
This ClinicalTrials.gov record has been amended 7 times since 2023-01-16; most recent amendment 2026-04-10.
Status change: Not Yet Recruiting → Recruiting 2024-12-20
Status change: Recruiting → Not Yet Recruiting 2024-03-06
Trial Details
NCT Number NCT05698745
Lead Sponsor Grupo Espanol de Trabajo en Enfermedad de Crohn y Colitis Ulcerosa
Conditions Crohn Disease, Ulcerative Colitis, IBD
Enrollment 450 participants
Start Date 2024-06-01
Primary Completion 2026-07-01 (estimated)
Study Completion 2038-07-01 (estimated)
Updated on ClinicalTrials.gov 2026-04-15